Paul Carlson
Company: FDA
Job title: Principal Investigator
Seminars:
Discussing the Role of CDMO’s in the LBP Industry 10:00 am
day: Day Two
Regulatory Considerations for Microbiome-based Therapeutics 9:30 am
Overview of investigational new drug protocol requirements CMC considerations for live biotherapeutic products CMC considerations for fecal transplant based productsRead more
day: Day Two